- Home
- MGX vs TPIC Comparison
MGX vs TPIC Comparison
Compare MGX & TPIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- TPIC
- Stock Information
- Founded
- MGX 2018
- TPIC 1968
- Country
- MGX United States
- TPIC United States
- Employees
- MGX N/A
- TPIC N/A
- Industry
- MGX
- TPIC Industrial Machinery/Components
- Sector
- MGX
- TPIC Industrials
- Exchange
- MGX NYSE
- TPIC Nasdaq
- Market Cap
- MGX 62.1M
- TPIC 58.4M
- IPO Year
- MGX 2024
- TPIC 2016
- Fundamental
- Price
- MGX $2.17
- TPIC $0.84
- Analyst Decision
- MGX Strong Buy
- TPIC Hold
- Analyst Count
- MGX 4
- TPIC 7
- Target Price
- MGX $13.00
- TPIC $1.68
- AVG Volume (30 Days)
- MGX 912.4K
- TPIC 893.3K
- Earning Date
- MGX 08-13-2025
- TPIC 08-07-2025
- Dividend Yield
- MGX N/A
- TPIC N/A
- EPS Growth
- MGX N/A
- TPIC N/A
- EPS
- MGX N/A
- TPIC N/A
- Revenue
- MGX $45,263,000.00
- TPIC $1,373,242,000.00
- Revenue This Year
- MGX N/A
- TPIC $10.66
- Revenue Next Year
- MGX $11.75
- TPIC $6.52
- P/E Ratio
- MGX N/A
- TPIC N/A
- Revenue Growth
- MGX N/A
- TPIC 3.05
- 52 Week Low
- MGX $1.23
- TPIC $0.64
- 52 Week High
- MGX $5.50
- TPIC $5.26
- Technical
- Relative Strength Index (RSI)
- MGX 71.83
- TPIC 37.37
- Support Level
- MGX $1.45
- TPIC $0.86
- Resistance Level
- MGX $2.47
- TPIC $1.01
- Average True Range (ATR)
- MGX 0.16
- TPIC 0.10
- MACD
- MGX 0.09
- TPIC -0.02
- Stochastic Oscillator
- MGX 75.47
- TPIC 6.43
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A (through MGX-001), Refractory Hypertension, Cardiovascular diseases, and Wilson's disease, among others.
About TPIC TPI Composites Inc.
TPI Composites Inc is engaged in manufacturing composite wind blades. The company operates in wind energy and transportation industries where it manufactures structures for a bus, rail, theme parks, and trucks. Geographically the segments are divided into the U.S, Asia, Mexico, EMEA and India where the Mexico segment derives a majority of revenue.